Guidance intends to help sponsors demonstrate Interchangeability with a reference product.
Real-time reporting of patient symptoms has shown proven health benefits.
Individuals enrolled in high-deductible health plans face thousands in out of pocket costs.
Histone H3 protein is abnormal or incorrectly modified in 15% of patients with head and neck cancer.
Study confirms safety and efficacy of Lu-177-PSMA-17 radioligand therapy for metastatic castration-resistant prostate cancer.
South African Pharmacy Council lifts ban preventing pharmacies from selling DIY HIV test kits.
CanChew Plus CBD gum may eventually treat irritable bowel disease, Crohn’s disease, and ulcerative colitis.

Product News

Granix is a human granulocyte factor produced in a bioreactor using recombinant DNA technology.
Complera treats HIV infection in previously untreated adults with a viral load of 100,000 copies/mL or less.
Repatha (evolocumab) treats primary hyperlipidemia in combination with dietary measures and maximally tolerated doses of statins.
Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate) is approved for treatment of HIV-1 infection.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Intellisphere, LLC. All Rights Reserved.